Ferring Pharmaceuticals: Nocturia trials

The registry lists 22 Nocturia studies with Ferring Pharmaceuticals as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 2 6Phase 3 8No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in AdultsCompletedNCT03201419Phase 2Results posted
• Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in WomenCompletedNCT01729819Phase 2Results posted
• Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact DiaryCompletedNCT01552343Phase 3Results posted
• Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male PatientsCompletedNCT01262456Phase 3Results posted
• Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female PatientsCompletedNCT01223937Phase 3Results posted
• Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and PlaceboCompletedNCT01184859Phase 2Results posted
• Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)CompletedNCT00902265Results posted
• An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in AdultsCompletedNCT00615836Phase 3Results posted
• Efficacy and Safety of Desmopressin Melt for the Treatment of NocturiaCompletedNCT00477490Phase 3Results posted
• NOCDURNA PASS Study Using Registries in Denmark, Germany and SwedenCompletedNCT04740645
• Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)CompletedNCT04329975
• A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the USCompletedNCT04125186
• Study of Minirin Melt® in Adult Patients With NocturiaTerminatedNCT03089073
• Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese SubjectsCompletedNCT03051009Phase 3
• Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female SubjectsCompletedNCT02905682Phase 3
• Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male SubjectsCompletedNCT02904759Phase 3
• Daytime Impact Sleep StudyTerminatedNCT01779466Phase 2
• Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult MenCompletedNCT01694498Phase 2
• Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult WomenCompletedNCT01684800Phase 2
• A Study of Minirin Melt in 24 Months Treatment in Patients With NocturiaCompletedNCT01552395
• A Study of Minirin Melt in Patients With NocturiaCompletedNCT01222598
• A Study of Minirin Melt in Patients With NocturiaCompletedNCT01212224